JPS57146713A - Hypoglycemic - Google Patents
HypoglycemicInfo
- Publication number
- JPS57146713A JPS57146713A JP3351381A JP3351381A JPS57146713A JP S57146713 A JPS57146713 A JP S57146713A JP 3351381 A JP3351381 A JP 3351381A JP 3351381 A JP3351381 A JP 3351381A JP S57146713 A JPS57146713 A JP S57146713A
- Authority
- JP
- Japan
- Prior art keywords
- digestive
- hypoglycemic
- saccharides
- active ingredients
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURPOSE: A hypoglycemic that contains saccharides selected from hard-digestive polysaccharides, oligosaccharides and their derivatives as active ingredients, thus being used as preventive and remedy for metabolic diseases or digestive diseases.
CONSTITUTION: The objective hypoglycemic is obtained by using saccharides selected from hard-digestive polysaccharides, oligosaccharides and these derivatives as active ingredients. The resultant hypoglycemic is effective for metabolic diseases such as hyperglycemic, diabetes, corpulency or arteriosclerosis, caused by excessive intake of readily digestive saccharides, especially starch or sucrose, and for preventing and treating digestive diseases such as diarrhea caused by unbalanced diet by excessive intake of readily digestive saccharides, gastrointestinal catarrh or abnormal itestinal fermentation. It is given orally, intraperitoneally or intravenously, however, it is suitable for oral administration more and is low toxicity. The saccharide as the active ingredients is produced by a microorganism or by a plant or animal, or obtained as its derivative.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3351381A JPS57146713A (en) | 1981-03-09 | 1981-03-09 | Hypoglycemic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3351381A JPS57146713A (en) | 1981-03-09 | 1981-03-09 | Hypoglycemic |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58186304A Division JPS59112922A (en) | 1983-10-05 | 1983-10-05 | Agent for lowering blood sugar |
JP58186305A Division JPS59113856A (en) | 1983-10-05 | 1983-10-05 | Saccharine food |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS57146713A true JPS57146713A (en) | 1982-09-10 |
Family
ID=12388621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3351381A Pending JPS57146713A (en) | 1981-03-09 | 1981-03-09 | Hypoglycemic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57146713A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5974976A (en) * | 1982-10-25 | 1984-04-27 | Yasutake Hichi | Drink and food containing suppressant against rise in value of blood sugar |
JPS604131A (en) * | 1983-06-21 | 1985-01-10 | Showa Sangyo Kk | Blood sugar lowering agent |
DE3421954C1 (en) * | 1984-06-13 | 1985-10-24 | Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen | Dietetic food containing hydroxyethyl starch |
JPS62201821A (en) * | 1986-02-28 | 1987-09-05 | Nippon Shokuhin Kako Kk | Substance for suppressing hyperglycemia |
US4818751A (en) * | 1985-07-02 | 1989-04-04 | Zeria Shinyaku Kogyo Kabushiki Kaisha | Cosmetics |
WO1991004751A1 (en) * | 1989-10-02 | 1991-04-18 | Shigeo Ochi | Inhibitor of absorption of digestion product of food and drink |
JP2006327959A (en) * | 2005-05-24 | 2006-12-07 | Toshitsu Kagaku Kenkyusho:Kk | Remedy for endocrine disease and metabolic disease |
US7423027B2 (en) | 2004-02-19 | 2008-09-09 | Abbott Laboratories | Methods of using gamma cyclodextrin to control blood glucose and insulin secretion |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52122342A (en) * | 1976-04-02 | 1977-10-14 | Bayer Ag | Amino sugar derivatives |
JPS52142018A (en) * | 1976-03-31 | 1977-11-26 | Magyar Tudomanyos Akademia | Essential ion complex |
JPS5323976A (en) * | 1976-08-13 | 1978-03-06 | Meiji Seika Kaisha Ltd | Nojirimycin. glucose oligomer and its preparation |
JPS5443599A (en) * | 1977-09-13 | 1979-04-06 | Murata Manufacturing Co | Piezooelectric crystalline membrane of zinc oxide |
JPS5492909A (en) * | 1977-12-28 | 1979-07-23 | Toyo Jozo Co Ltd | New aminosaccharide and its preparation |
JPS54163511A (en) * | 1978-02-14 | 1979-12-26 | Hoffmann La Roche | Aminosugar derivative |
-
1981
- 1981-03-09 JP JP3351381A patent/JPS57146713A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52142018A (en) * | 1976-03-31 | 1977-11-26 | Magyar Tudomanyos Akademia | Essential ion complex |
JPS52122342A (en) * | 1976-04-02 | 1977-10-14 | Bayer Ag | Amino sugar derivatives |
JPS5323976A (en) * | 1976-08-13 | 1978-03-06 | Meiji Seika Kaisha Ltd | Nojirimycin. glucose oligomer and its preparation |
JPS5443599A (en) * | 1977-09-13 | 1979-04-06 | Murata Manufacturing Co | Piezooelectric crystalline membrane of zinc oxide |
JPS5492909A (en) * | 1977-12-28 | 1979-07-23 | Toyo Jozo Co Ltd | New aminosaccharide and its preparation |
JPS54163511A (en) * | 1978-02-14 | 1979-12-26 | Hoffmann La Roche | Aminosugar derivative |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5974976A (en) * | 1982-10-25 | 1984-04-27 | Yasutake Hichi | Drink and food containing suppressant against rise in value of blood sugar |
JPS6153029B2 (en) * | 1982-10-25 | 1986-11-15 | Yasutake Hichi | |
JPS604131A (en) * | 1983-06-21 | 1985-01-10 | Showa Sangyo Kk | Blood sugar lowering agent |
DE3421954C1 (en) * | 1984-06-13 | 1985-10-24 | Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen | Dietetic food containing hydroxyethyl starch |
US4818751A (en) * | 1985-07-02 | 1989-04-04 | Zeria Shinyaku Kogyo Kabushiki Kaisha | Cosmetics |
JPS62201821A (en) * | 1986-02-28 | 1987-09-05 | Nippon Shokuhin Kako Kk | Substance for suppressing hyperglycemia |
WO1991004751A1 (en) * | 1989-10-02 | 1991-04-18 | Shigeo Ochi | Inhibitor of absorption of digestion product of food and drink |
US5364636A (en) * | 1989-10-02 | 1994-11-15 | Hanabusa Patent Office | Inhibitor of absorption of digestion product of food and drink |
US7423027B2 (en) | 2004-02-19 | 2008-09-09 | Abbott Laboratories | Methods of using gamma cyclodextrin to control blood glucose and insulin secretion |
US8420621B2 (en) | 2004-02-19 | 2013-04-16 | Abbott Laboratories | Methods of using gamma cyclodextrin to control blood glucose and insulin secretion |
JP2006327959A (en) * | 2005-05-24 | 2006-12-07 | Toshitsu Kagaku Kenkyusho:Kk | Remedy for endocrine disease and metabolic disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69910559T2 (en) | NEW FAT ANALOGS FOR THE TREATMENT OF OBESITY | |
Ravi et al. | Anti-diabetic activity of Eugenia jambolana seed kernels on streptozotocin-induced diabetic rats | |
Capasso et al. | Antipyretic and antibacterial actions of Teucrium polium (L.) | |
Satoh et al. | Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics | |
DE69533593T2 (en) | PREPARATIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDER CONTAINING ARABINOGALACTAN AND POLYPHENOLS OF LARIX. | |
US5318986A (en) | Method of inhibiting the activity of α-amylase | |
Satoh et al. | Role of food in gastrointestinal ulceration produced by indomethacin in the rat | |
DE3500179A1 (en) | ACETYLERYTHROMYCINSTEARATE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCT CONTAINING THIS | |
JPS57146713A (en) | Hypoglycemic | |
Deeptha et al. | Dose dependent inhibitory effect of dietary caraway on 1, 2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats | |
IE780098L (en) | Safeguarded toxic chemical compositions containing an¹emetic | |
Yeşilada et al. | Anti-ulcerogenic effects of Spartium junceum flowers on in vivo test models in rats | |
DE2921328C3 (en) | Medicines for the treatment of hyperglycaemia, hyperlipemia, hypertension, inflammatory diseases, pain, pyrexia and tumors | |
US5464620A (en) | Pharmaceutical composition for treating gastrointestinal disease | |
DE2206570A1 (en) | Remedies for treating liver affections | |
US4328246A (en) | Anti Walker 256 carcinoma agent and combination thereof | |
Fabia et al. | Effect of pentoxifylline on hepatic ischemia and reperfusion injury | |
Salim | Use of scavenging oxygen‐derived free radicals to protect the rat against aspirin‐and ethanol‐induced erosive gastritis | |
US6638523B1 (en) | Method of treating ulcers | |
JPS5430146A (en) | Novel anthracycline derivatives and their preparation | |
JPH08231396A (en) | Anti-helicobacter pylori medicine | |
Gustafsson et al. | Prolonged induction of germfree bile acid pattern in conventional rats by antibiotics | |
CH644018A5 (en) | PHARMACEUTICAL AGENT FOR PROSTAGLAND REGULATION. | |
JPS55122715A (en) | Antidiabetic agent | |
DE2759108A1 (en) | USE OF ALPHA -MERCAPTO-BETA-ARYL-ACRYLIC ACIDS IN INCREASING THE ZINC CONTENT IN SERUM AND TISSUE |